A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

NCT01229319 ·Status: UNKNOWN ·Phase: PHASE4

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

NCT00110682 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

NCT00894647 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

NCT00603798 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

NCT00605176 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

NCT01788007 ·Status: COMPLETED ·Phase: PHASE1

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

NCT01686152 ·Status: COMPLETED ·Phase: PHASE3

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

NCT04842422 ·Status: COMPLETED ·Phase: PHASE4

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

NCT00116649 ·Status: COMPLETED ·Phase: PHASE4

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

NCT01836367 ·Status: COMPLETED ·Phase: PHASE1

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

NCT03914417 ·Status: COMPLETED ·Phase: PHASE2

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

NCT01413763 ·Status: UNKNOWN ·Phase: PHASE4

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

NCT01203878 ·Status: TERMINATED ·Phase: PHASE4

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

NCT00859105 ·Status: COMPLETED ·Phase: PHASE3

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

NCT00335179 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis

NCT03210740 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

NCT00948428 ·Status: COMPLETED ·Phase: PHASE3

IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis

NCT02281682 ·Status: UNKNOWN ·Phase: PHASE4

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

NCT00115154 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

NCT06135415 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

NCT00294320 ·Status: COMPLETED ·Phase: PHASE3

Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses

NCT02473848 ·Status: TERMINATED ·Phase: PHASE3

Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis

NCT02242747 ·Status: COMPLETED ·Phase: NA

Treatment of Actinic Keratoses (AK) on the Face

NCT02411851 ·Status: COMPLETED ·Phase: PHASE1

Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis

NCT06319794 ·Status: COMPLETED ·Phase: PHASE2